Projects per year
Personal profile
External positions
Health Science Specialist, Minneapolis VA Healthcare System
2008 → …Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 7 Similar Profiles
Casein Kinase II
Medicine & Life Sciences
Nanocapsules
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Cyclin-Dependent Kinases
Medicine & Life Sciences
Cyclins
Medicine & Life Sciences
RNA Interference
Medicine & Life Sciences
Heterografts
Medicine & Life Sciences
Cell Death
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2011 2020
CK2 in prostate cancer patient blood – promising therapy target to improve outcomes
10/1/19 → 9/30/20
Project: Research project
CK2 in prostate cancer patient blood – promising target for improving therapy
Trembley, J. H. & Ahmed, K.
10/1/19 → 9/30/20
Project: Research project
Tumor-targeted anti-CK2 RNAi for treatment of HCC
NIH NATIONAL CANCER INSTITUTE (NCI)
9/10/12 → 9/1/14
Project: Research project
RNA Interference
Neoplasms
A Novel Therapeutic Approach for Primary and Metastatic
Ahmed, K., Slaton, J., Trembley, J. H., Zimmerman, C. L., Kren, B. J. & Vogel, R.
NIH NATIONAL CANCER INSTITUTE (NCI)
3/4/11 → 2/28/17
Project: Research project
Prostatic Neoplasms
Therapeutics
Research Output 1994 2019
1
Citation
(Scopus)
CDK11 loss induces cell cycle dysfunction and death of BRAF and NRAS Melanoma Cells
Ahmed-Saucedo, R. L., Shaughnessy, D. P., Knutson, T. P., Vogel, R. I., Ahmed, K., Kren, B. J. & Trembley, J. H., Jun 1 2019, In : Pharmaceuticals. 12, 2, 50.Research output: Contribution to journal › Article
Open Access
Cyclin-Dependent Kinases
Melanoma
Cell Cycle
Cell Death
Cyclins
CK2 pro-survival role in prostate cancer is mediated via maintenance and promotion of androgen receptor and NFκB p65 expression
Trembley, J. H., Kren, B. J., Abedin, M. J., Shaughnessy, D. P., Li, Y., Dehm, S. M. & Ahmed, K., Jun 1 2019, In : Pharmaceuticals. 12, 2, 89.Research output: Contribution to journal › Article
Open Access
NF-kappa B
Androgen Receptors
Prostatic Neoplasms
Maintenance
Prostate
23
Citations
(Scopus)
Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy
Kren, B. J., Unger, G. M., Abedin, M. J., Vogel, R. I., Henzler, C. M., Ahmed, K. & Trembley, J. H., Feb 11 2015, In : Breast Cancer Research. 17, 1, 19.Research output: Contribution to journal › Article
Triple Negative Breast Neoplasms
Casein Kinase II
Cyclin-Dependent Kinases
RNA Interference
Phosphotransferases
Improving Health Care for Veterans With Gulf War Illness
Baldwin, N., Rudquist, R. R., Lava-Parmele, S., Trembley, J. H., Butterick, T. A. & Bach, R. R., May 2019, In : Federal practitioner : for the health care professionals of the VA, DoD, and PHS. 36, 5, p. 212-219 8 p.Research output: Contribution to journal › Article
Gulf War
Veterans
Chronic Disease
Delivery of Health Care
Physicians
3
Citations
(Scopus)
CK2 molecular targeting-tumor cell-specific delivery of RNAi in various models of cancer
Trembley, J. H., Kren, B. J., Abedin, M. J., Vogel, R. I., Cannon, C. M., Unger, G. M. & Ahmed, K., Feb 21 2017, In : Pharmaceuticals. 10, 1, 25.Research output: Contribution to journal › Review article
RNA Interference
Nanocapsules
Neoplasms
Tenascin
Casein Kinase II